AbbVie sets up shop in Singapore

The new manufacturing site will be its first in Asia.

February 6, 2014

6:38 pm

AbbVie is establishing roots in Asia. The drugmaker announced Thursday that it was investing $320 million to build the manufacturing facility in Singapore—its first manufacturing site in all of Asia. The site will be focused on emerging oncology and immunology products.

The company said in a statement it expects the site will be fully operational by 2019 and will employ around 250.

AbbVie split from Abbott Laboratories in January 2013.

From Our Partners

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

Partner Content

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

The evolution of patient needs and rising consumer expectations are shaping a new era in healthcare — one that calls for a paradigm shift in the pharmaceutical industry's approach to patient support.

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.

Taking a patient-centric approach to privacy

Partner Content

Taking a patient-centric approach to privacy

This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent.

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.